Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Editors Pick
    • CDSCO, Saudi Food and...

    CDSCO, Saudi Food and Drug Authority ink agreement for medical products regulations

    Medical Dialogues BureauWritten by Medical Dialogues Bureau Published On 2019-11-03T10:24:33+05:30  |  Updated On 17 Aug 2021 12:43 PM IST

    An MoU was signed between the Central Drugs Standard Control Organisation (CDSCO), Ministry of Health and Family Welfare and Saudi Food and Drug Authority (SFDA) for cooperation in the field of medical products regulations.


    New Delhi: India and Saudi Arabia on Tuesday signed 12 MoUs and agreements in key sectors including defence industries collaboration, renewable energy, security cooperation and civil aviation.


    The agreements were signed in the presence of Prime Minister Narendra Modi and Saudi Crown Prince Mohammed bin Salman.


    The two countries signed a Strategic Partnership Council Agreement to further cement the bilateral ties in political, defence, security, trade and investment sectors between the two countries.


    An MoU was inked on cooperation in the field of renewable energy between the Saudi Ministry of Energy and India's Ministry of New and Renewable Energy.


    Two separate agreements on security cooperation and civil aviation cooperation were signed between the two sides.


    An MoU was signed for cooperation in the field of combating illicit trafficking and smuggling of narcotic drugs, psychotropic substances and chemical precursors.


    An MoU was reached between the Saudi General Authority of Military Industries (GAMI) and Department of Defence Production, Ministry of Defence concerning collaboration in a military acquisition, industries, research, development and technology.


    An MoU was signed between the Central Drugs Standard Control Organisation (CDSCO), Ministry of Health and Family Welfare and Saudi Food and Drug Authority (SFDA) for cooperation in the field of medical products regulations.


    Furthermore, a Letter of Intent was inked between Small and Medium Enterprises General Authority (Monshaat) of Saudi Arabia and Atal Innovation Mission (AIM), NITI Aayog.


    An agreement on cooperation programme was reached between the Foreign Service Institute, MEA and Prince Saud Al Faisal Institute of Diplomatic Studies (IDS) of the Ministry of Foreign Affairs of Saudi Arabia.


    An MoU was signed between Indian Strategic Petroleum Reserves Limited (ISPRL) and Saudi Aramco between the two sides.


    Moreover, an MoU was inked for cooperation between National Stock Exchange (NSE) and the Saudi Stock Exchange (Tadawul).


    An MoU was signed between National Payments Corporation of India (NPCI) and Saudi Payments.


    Modi held "fruitful discussions" with the Crown Prince on "adding greater dynamism and depth to the bilateral strategic partnership", according to MEA spokesperson Raveesh Kumar.


    Read Also: Biomed writes to Health Ministry saying it can supply vaccines for Haj pilgrims


    "Sustaining the momentum of regular high-level contacts. PM @narendramodi held fruitful discussions with Crown Prince HRH Mohammed bin Salman, a close friend of India, on adding greater dynamism and depth to the bilateral strategic partnership," he tweeted.


    Earlier, the Prime Minister delivered the keynote address at the third Future Investment Initiative (FII), also dubbed as the 'Davos in the Desert' and met with several ministers of the Saudi leadership.


    Modi arrived in Riyadh on a two-day visit to the Kingdom. He is slated to leave for New Delhi on Tuesday night.


    Read Also: Serum Institute to unveil thermostable rotavirus vaccine Rotasiil in 9 countries next year

    aimarabiaAtal Innovation MissionCDSCOCentral Drugs Standard Control Organisationchemical precursorscivil aviationGAMIHealth and Family WelfareIndiaindian pmIndian Strategic Petroleum Reserves LimitedISPRLmedical productsModiMohammed bin SalmanMoHFWMoUsNarcotic DrugsNarendra ModiNational Stock ExchangeNiti AayogNSEpsychotropicsaudiSaudi Food and Drug AuthoritySFDAsmugglingtrafficking
    Source : ANI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok